Mastocytosis

0:04:08

Is It Systemic Mastocytosis? Best Practices for Diagnosis and Management

0:01:44

Emerging novel agents for the treatment of mastocytosis

0:06:56

What Is Mastocytosis?

0:01:46

The recent updates to the NCCN Guidelines for systemic mastocytosis

0:03:05

EXPLORER: Avapritinib in systemic mastocytosis

0:03:17

Dr. Lee Sees a Patient With Mast Cell Disease | Dr. Pimple Popper

0:02:07

Avapritinib for indolent systemic mastocytosis

0:04:05

Future Approaches in Advanced Mastocytosis

0:03:04

Diagnosing Mastocytosis

0:20:46

Biology and therapy of advanced systemic mastocytosis

0:03:37

Changes in mast cell number & immunophenotype in patients with mastocytosis treated with avapritinib

0:02:21

Avapritinib updates in advanced systemic mastocytosis: EXPLORER and PIONEER

0:04:41

Mastocytosis (Urticaria Pigmentosa): 5-Minute Pathology Pearls

0:09:29

PIONEER: avapritinib in patients with indolent systemic mastocytosis

0:01:10

Avapritinib for advanced systemic mastocytosis: analysis of patient-reported outcomes from EXPLORER

0:02:37

Current approaches to treating systemic mastocytosis

0:04:19

Interview met Andrew: leven met mastocytosis

0:05:07

Using Pathology to Diagnose Nonadvanced Systemic Mastocytosis

0:01:44

The efficacy and safety of bezuclastinib in non-advanced systemic mastocytosis

0:01:41

The current therapeutic landscape for indolent and advanced systemic mastocytosis

0:01:43

ddPCR detects KIT D816V mutations with high sensitivity in systemic mastocytosis

0:03:46

An update on the SUMMIT trial: bezuclastinib in non-advanced systemic mastocytosis

0:02:56

Insights into the treatment and management of advanced systemic mastocytosis

0:09:24

Indolent Systemic Mastocytosis and the Patient Experience